Differences in classification schemata for myelodysplastic/myeloproliferative overlap neoplasms

被引：3

作者：

Patnaik, Mrinal M. ^{[1
]}

Zeidan, Amer M. ^{[2
,3
]}

Padron, Eric ^{[4
]}

Platzbecker, Uwe ^{[5
]}

Sallman, David A. ^{[4
]}

DeZern, Amy E. ^{[6
,7
]}

Bejar, Rafael ^{[8
]}

Sekeres, Mikkael ^{[9
]}

Taylor, Justin ^{[9
]}

Little, Richard F. ^{[10
]}

Bewersdorf, Jan P. ^{[11
]}

Kim, Tae Kon. ^{[12
]}

Kim, Nina ^{[10
]}

Hourigan, Christopher S. ^{[10
]}

Dela Porta, Matteo G. ^{[13
,14
]}

Stahl, Maximilian ^{[15
,16
]}

Steensma, David ^{[17
]}

Xu, Mina L. ^{[3
,18
,19
]}

Odenike, Olatoyosi ^{[20
]}

Carraway, Hetty ^{[21
]}

Fenaux, Pierre ^{[22
,23
]}

Nazha, Aziz ^{[24
]}

Komrokji, Rami ^{[4
]}

Loghavi, Sanam ^{[25
]}

Xie, Zhuoer ^{[4
]}

Hasserjian, Robert ^{[26
]}

Savona, Michael ^{[12
]}

Bennett, John M. ^{[27
]}

机构：

[1] Mayo Clin, Div Hematol, Dept Internal Med, Rochester, MN 55905 USA

[2] Yale Univ, Sch Med, Dept Internal Med, Sect Hematol, New Haven, CT 06510 USA

[3] Yale Canc Ctr, New Haven, CT USA

[4] H Lee Moffitt Canc Ctr & Res Inst, Malignant Hematol, Tampa, FL USA

[5] Univ Leipzig, Dept Hematol, Leipzig, Germany

[6] Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Div Hematol Malignancies, Baltimore, MD USA

[7] Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Dept Oncol, Baltimore, MD USA

[8] Univ Calif San Diego, Moores Canc Ctr, Div Hematol & Oncol, La Jolla, CA USA

[9] Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA

[10] NCI, NIH, Bethesda, MD 20892 USA

[11] Mem Sloan Kettering Canc Ctr, Dept Med, Leukemia Serv, 1275 York Ave, New York, NY 10021 USA

[12] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Div Hematol, Nashville, TN 37212 USA

[13] Humanitas Clin & Res Ctr, Milan, Italy

[14] Humanitas Univ, Dept Biomed Sci, Milan, Italy

[15] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA

[16] Harvard Med Sch, Boston, MA 02115 USA

[17] Novartis Inst Blood Res, Boston, MA USA

[18] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA

[19] Yale Univ, Sch Med, Dept Lab Med, New Haven, CT 06510 USA

[20] Univ Chicago Med, Hematol Oncol Sect, Chicago, IL USA

[21] Cleveland Clin, Taussig Canc Inst, Leukemia Program, Cleveland, OH 44106 USA

[22] Hop St Louis, Assistance Publ Hop Paris, Paris, France

[23] Univ Paris Cite, Paris, France

[24] Thomas Jefferson Univ, Sidney Kimmel Canc Ctr, Dept Med Oncol, Philadelphia, PA 19107 USA

[25] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA

[26] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA

[27] Univ Rochester, Med Ctr, Dept Med Pathol & Lab Med, Rochester, NY 14642 USA

来源：

LEUKEMIA | 2022年 / 36卷 / 12期

关键词：

HEALTH-ORGANIZATION CLASSIFICATION; REVISION; LEUKEMIA;

D O I：

10.1038/s41375-022-01754-3

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：2934 / 2938

页数：5

共 50 条

[31] Myelodysplastic/myeloproliferative neoplasms: a disease in need of recognition
Khan, Maliha
Sarfraz, Maryam
Daver, Naval
FUTURE ONCOLOGY, 2017, 13 (02) : 117 - 120
[32] Characteristics of the four subtypes of myelodysplastic/myeloproliferative neoplasms
Wu, Huanling
Bian, Shuquan
Chu, Jingxue
Zhong, Xiaoyan
Sun, Hui
Zhang, Bingchang
Lu, Zhiming
EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2013, 5 (05) : 1332 - 1338
[33] Antitumour activity of trabectedin in myelodysplastic/myeloproliferative neoplasms
Romano, Michela
Della Porta, Matteo Giovanni
Galli, Anna
Panini, Nicolo
Licandro, Simonetta Andrea
Bello, Ezia
Craparotta, Ilaria
Rosti, Vittorio
Bonetti, Elisa
Tancredi, Richard
Rossi, Marianna
Mannarino, Laura
Marchini, Sergio
Porcu, Luca
Galmarini, Carlos M.
Zambelli, Alberto
Zecca, Marco
Locatelli, Franco
Cazzola, Mario
Biondi, Andrea
Rambaldi, Alessandro
Allavena, Paola
Erba, Eugenio
D'Incalci, Maurizio
BRITISH JOURNAL OF CANCER, 2017, 116 (03) : 335 - 343
[34] Epidemiology of myeloproliferative neoplasms and myelodysplastic syndromes in Germany
Kraywinkel, Klaus
ONKOLOGE, 2019, 25 (11): : 948 - 956
[35] Challenges in Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN)
Smith, Brianna N.
Savona, Michael
Komrokji, Rami S.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (01): : 1 - 8
[36] Transcription factor mutations in myelodysplastic/myeloproliferative neoplasms
Ernst, Thomas
Chase, Andrew
Zoi, Katerina
Waghorn, Katherine
Hidalgo-Curtis, Claire
Score, Joannah
Jones, Amy
Grand, Francis
Reiter, Andreas
Hochhaus, Andreas
Cross, Nicholas C. P.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 (09): : 1473 - 1480
[37] Pediatric myelodysplastic/myeloproliferative neoplasms and related diseases
Karthik A. Ganapathi
Kristian T. Schafernak
V. Koneti Rao
Katherine R. Calvo
Journal of Hematopathology, 2015, 8 : 159 - 167
[38] Antitumour activity of trabectedin in myelodysplastic/myeloproliferative neoplasms
Michela Romano
Matteo Giovanni Della Porta
Anna Gallì
Nicolò Panini
Simonetta Andrea Licandro
Ezia Bello
Ilaria Craparotta
Vittorio Rosti
Elisa Bonetti
Richard Tancredi
Marianna Rossi
Laura Mannarino
Sergio Marchini
Luca Porcu
Carlos M Galmarini
Alberto Zambelli
Marco Zecca
Franco Locatelli
Mario Cazzola
Andrea Biondi
Alessandro Rambaldi
Paola Allavena
Eugenio Erba
Maurizio D'Incalci
British Journal of Cancer, 2017, 116 : 335 - 343
[39] Pediatric myelodysplastic/myeloproliferative neoplasms and related diseases
Ganapathi, Karthik A.
Schafernak, Kristian T.
Rao, V. Koneti
Calvo, Katherine R.
JOURNAL OF HEMATOPATHOLOGY, 2015, 8 (03) : 159 - 167
[40] Renal post-mortem findings in myeloproliferative and myelodysplastic/myeloproliferative neoplasms
Person, Fermin
Meyer, Sara C.
Hopfer, Helmut
Menter, Thomas
VIRCHOWS ARCHIV, 2021, 479 (05) : 1013 - 1020

← 1 2 3 4 5 →